ATDBio is proud to highlight its ongoing collaboration with YouSeq, one of Britain's fastest-growing private tech companies, as recognized in The Sunday Times Tech 100 list. This partnership exemplifies how expertise in oligonucleotide synthesis enables rapid development and deployment of cutting-edge molecular diagnostic solutions.

The partnership has focused on developing sophisticated molecular diagnostic tests with remarkable speed and precision. At the heart of YouSeq's innovative qPCR and NGS-based tests lies a critical component: high-quality oligonucleotides that ensure exceptional sensitivity and specificity.

We require the highest quality oligos to ensure that our products achieve the levels of sensitivity and specificity that are so important to us, our customers, and the patients whose lives are ultimately affected by our tests. We've worked with ATDBio for many years now as a trusted partner. The quality of the product is fantastic - they do produce the best oligos in the business - and critically, the customer service that we receive is outstanding.

Jim Wicks

Co-founder and Executive Chair, YouSeq

Recently, the two companies have joined forces to develop innovative tests for emerging threats like mpox, highlighting their agility and commitment to delivering timely solutions that make a significant impact on public health. As both companies look to the future, they continue to work together to advance molecular diagnostics and improve healthcare solutions.